Category Archives: Life_Sciences

Washington companies win $34 million in Therapeutic Discovery Project Grants

Washington life sciences companies won more than $34 million in grants through the U.S. Internal Revenue Service under the Qualifying Therapeutic Discovery Project Program which was created by the Affordable Care Act. The grant covers up to 50 percent of … Continue reading

Posted in EKOS, Funding, Healionics, Insilicos, IsoRay, Life_Sciences, NanoString_Technologies, Omeros, Pathway_Medical_Technologies, Stratos_Genomics, VisionGate | Leave a comment

Life Sciences Discovery Fund to start new initiative with Omeros proceeds

Washington’s Life Sciences Discovery Fund (LSDF) announced “a $5 million grant to Seattle-based Omeros Corporation to discover, develop, and commercialize new drugs to treat a variety of major diseases. With successful generation of proceeds through partnering and the sales of … Continue reading

Posted in Company_and_Client_News, Funding, Life_Sciences, Life_Sciences_Discovery_Fund, Omeros | Leave a comment

Omeros gains $20M from Vulcan and $5M from Life Sciences Discovery Fund

Omeros Corporation, a Seattle-based clinical-stage biopharmaceutical company, announced “that it has received $20 million from Vulcan Capital (Vulcan) and a grant award for $5 million from Washington State’s Life Sciences Discovery Fund (LSDF) to support the advancement of the Company’s … Continue reading

Posted in Company_and_Client_News, Funding, Life_Sciences, Life_Sciences_Discovery_Fund, Omeros | Leave a comment

WBBA: Innovative Investing in Global Health – Nov. 3, 2010 – Seattle

Washington Biotechnology & Biomedical Association presents “Innovative Investing in Global Health: What’s in it for your organization?” on Wednesday November 3, 2010 from 5-7 p.m. at Seattle Biomedical Research Institute. Program panelists include moderator Melinda Moree of BIO Ventures for … Continue reading

Posted in Events, Life_Sciences, Partner_News_and_More, WBBA | Leave a comment

Omeros addiction program study wins $3.6M federal grant

Omeros Corporation, a Seattle-based clinical-stage biopharmaceutical company, announced that the National Institute on Drug Abuse (part of the NIH) has provided an additional grant — $3.6 million over four years — to fund clinical studies for the company’s addiction program. … Continue reading

Posted in Company_and_Client_News, Funding, Life_Sciences, Omeros | Leave a comment

Insilicos wins $1.2M NIH grant

Insilicos, a developer of life science software, has been awarded a $1.2 million SBIR grant from the National Institutes of Health to conduct a 400-subject evaluation of its PreClue diagnostic test for cardiovascular disease. The study, which will take place … Continue reading

Posted in Company_and_Client_News, Funding, Insilicos, Life_Sciences | Leave a comment

Stratos Genomics raises $4M in Series-A round

Stratos Genomics, a Seattle-based startup focusing on low-cost DNA sequencing technology, closed a $4 million Series-A financing round led by Fisk Ventures. “The Stratos Genomics technology has the potential to revolutionize personalized medicine and bring genome sequencing technology to all. … Continue reading

Posted in Company_and_Client_News, Funding, Life_Sciences, Stratos_Genomics | Leave a comment